Published in Urologe A on November 01, 1982
Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer. Strahlenther Onkol (1998) 1.38
Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys (1990) 1.17
Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys (1998) 1.16
Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys (2000) 1.07
What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol (1991) 1.06
[Fornix rupture--a review of pathophysiology and clinical aspects]. Urologe A (1989) 1.06
[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06
[Iohexol in excretory urography. Results of drug monitoring]. Fortschr Med (1986) 0.97
Double-blind study with thiazide in recurrent calcium lithiasis. J Urol (1982) 0.95
Organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int J Radiat Oncol Biol Phys (1994) 0.94
Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose. Eur Urol (2001) 0.93
In vitro study concerning the efficiency of the frequency-doubled double-pulse Neodymium:YAG laser (FREDDY) for lithotripsy of calculi in the urinary tract. Lasers Surg Med (1999) 0.91
[Continent reconstruction of an extreme urogenital sinus--case report of a so-called high vesicovaginal confluence]. Urologe A (1988) 0.90
[Cryotherapy of bladder cancer]. Urologe (1968) 0.89
Evaluation of the new tumor, nodes and metastases classification of renal cell carcinoma. J Urol (1990) 0.87
[Retroperitoneal ganglioneuroma]. Aktuelle Urol (2005) 0.87
Invasive bladder cancer: organ preservation by radiochemotherapy. Front Radiat Ther Oncol (2002) 0.86
Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res (1999) 0.86
Comparison of preoperative innervation pattern and postreconstructive urodynamics in the exstrophy-epispadias complex. Urol Int (1997) 0.84
[The significance of tumor diameter in renal cell carcinoma]. Urologe A (1992) 0.84
Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy. Semin Surg Oncol (2001) 0.83
Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism. Invest Urol (1979) 0.80
[The reaction of the healthy urinary bladder to extreme cold lesion. Experimental studies with liquid nitrogen]. Urologe (1968) 0.80
[Relationship between sound size, freezing speed and cell death in cryotherapy]. Urologe (1970) 0.80
Does the distance to normal renal parenchyma (DTNRP) in nephron-sparing surgery for renal cell carcinoma have an effect on survival? Anticancer Res (2005) 0.80
Mineral metabolism during prolonged oral calcium substitution after jejuno-ileal bypass for morbid obesity. Klin Wochenschr (1982) 0.79
PROGINS polymorphism of progesterone receptor is increased in female offspring with maternal exposure to diethylstilbestrol. Anticancer Res (2001) 0.79
[Sonography in the early detection of non-palpable second testicular tumors: a prospective study]. Urologe A (1987) 0.79
Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines. Anticancer Res (2007) 0.79
Metal ions in biological systems, volume 35: iron transport and storage microorganisms, plants, and animals. Met Based Drugs (1998) 0.79
[Endometriosis of the ureter and urinary bladder]. Urologe A (2007) 0.78
[Congenital megaureter and its implications]. Urologe A (1982) 0.78
Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic. Nephron (1982) 0.78
Epidermal growth factor receptor and g250: useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma? J Urol (2002) 0.78
Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Strahlenther Onkol (2001) 0.78
Necessary extent of lymph node dissection in testicular tumours. A histopathological investigation. Eur Urol (1982) 0.78
Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma. Anticancer Res (1999) 0.77
[Ventral urethral diverticulum. Case report of a 10-year-old girl]. Urologe A (1999) 0.76
Preliminary results of treatment of invasive bladder carcinoma with radiotherapy and cisplatin. Int J Radiat Oncol Biol Phys (1988) 0.76
Urological complications in chronic inflammatory diseases of the bowel. Eur Urol (1977) 0.76
Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine. Urol Res (1979) 0.75
Histological grading of renal cell carcinoma. Eur Urol (1976) 0.75
Femoral duplication and the developmental field. Am J Med Genet (1990) 0.75
Prostatic acid phosphatase in the serially transplantable human prostatic tumor lines PC-82 and PC-EW. Urol Res (1990) 0.75
Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy. Klin Wochenschr (1983) 0.75
[Urological relevance of pelvic fractures]. Helv Chir Acta (1981) 0.75
Cryotherapy of heterotransplanted human cancer: preliminary experimental findings in the Syrian hamster. Urol Int (1969) 0.75
[Injuries of the ureter caused by external force]. Urologe A (1984) 0.75
[Retroperitoneal lymph dissection of testicular cancer]. Chirurg (1983) 0.75
[The pharmacological treatment of the incontinent neurogenic bladder (author's transl)]. Urologe A (1978) 0.75
[Improved actuarial results in the treatment of kidney cancer by systematic lymph node excision]. J Urol (Paris) (1989) 0.75
[Ureteral injuries caused by external force]. Urologe A (1995) 0.75
[Urination disorders following general surgery]. Z Urol Nephrol (1978) 0.75
Effects of a cation exchange resin on intestinal calcium absorption and urinary calcium in calcium stone formers. Urol Res (1981) 0.75
[Surgery of the kidney tumor]. Chirurg (1981) 0.75
[The approach in urology--the lumbar approach]. Helv Chir Acta (1984) 0.75
[Pathogenetic synopsis of diverticular disease of the female urethra]. Urologe A (1988) 0.75
[Urinary oxalate in recurrent calcium urolithiasis with and without hyperfunctioning parathyroid glands and in healthy controls. influence of age and season (author's transl)]. Urologe A (1979) 0.75
Technique and results of the colonic conduit, continent by means of a new magnetic stoma seal an experimental study. Br J Urol (1978) 0.75
[Desobstructive sodium and water diuresis: pathophysiologic and clinical aspects of bilateral obstructive nephropathy (author's transl)]. Urol Int (1979) 0.75
[Injuries of the ureter caused by external forces]. Helv Chir Acta (1983) 0.75
[The apparaturs for cryosurgery]. Urologe (1968) 0.75
[Varicocele and distal reflux]. Urologe A (1982) 0.75
[Kidney transplantation. Indications, conditions and results]. Fortschr Med (1982) 0.75
[Increased quality of the donor kidney due to en bloc binephrectomy (author's transl)]. Urologe A (1981) 0.75
[Bladder diverticulum, a congenital disease of children and adults]. Urologe A (1982) 0.75
[Conservative and surgical therapy of vesicoureterorenal reflux]. Urologe A (1983) 0.75
[Repair of megaureter by tailoring in two layers while preserving vascular supply (author's transl)]. Z Kinderchir (1982) 0.75
[Heparin-induced type II thrombocytopenia as the etiology of severe recurrent pulmonary embolism]. Pneumologie (2001) 0.75
[Urolithiasis - a review of pathophysiology, diagnostic procedures and therapy (author's transl)]. Wien Klin Wochenschr (1980) 0.75
Transvenous perfusion cooling of the kidney: a new technique of local renal hypothermia. Invest Urol (1978) 0.75
[Classification and prognosis of supravesical urothelioma with the new TNM classification]. Urologe A (1994) 0.75
[Side effects of cryotherapy on large blood vessels]. Urologe (1971) 0.75
[Immunosuppressive therapy following kidney transplantation]. Urologe A (1982) 0.75
[Reflux persisting into adulthood. A clinical study]. Urologe A (1983) 0.75
[Classification of staghorn calculus disease of the kidney based on 105 personal cases and a review of the literature]. Urologe A (1986) 0.75
[Effective treatment of urolithiasis requires metabolic classification (author's transl)]. Urologe A (1980) 0.75
[What is the benefit of systematic regional lymph node dissection in tumor nephrectomy?]. Helv Chir Acta (1990) 0.75
[Sarcoma of the urogenital tract in children]. Urologe A (1982) 0.75
[Neoplasia of the adrenal gland--surgical problems, approaches and the need for blood]. Helv Chir Acta (1989) 0.75
[Method of radical transabdominal tumor nephrectomy with facultative or systemic lymph node dissection and results in 381 patients]. Urologe A (1984) 0.75
Parathyroid gland function in subgroups of metabolically mediated urolithiasis as evaluated by serum parathyroid hormone, and urinary and nephrogenous cyclic nucleotides. Klin Wochenschr (1982) 0.75
[Transvenous perfusion, a new simple and effective technique of regional renal hypothermia. An experimental study (author's transl)]. Langenbecks Arch Chir (1978) 0.75
[Sacral dysgenesis and its neuro-urologic pathologic correlates]. Urologe A (1982) 0.75
[Congenital abnormalities of the upper urinary tract--bases and results of surgical therapy]. Helv Chir Acta (1986) 0.75
[Germinal testicular carcinoma. Clinical aspects, differential diagnosis, indications and surgical treatment of retroperitoneal metastases]. MMW Munch Med Wochenschr (1984) 0.75
[Urinary stasis in benign prostatism]. Z Urol Nephrol (1965) 0.75
Determination of urinary oxalate by isotachophoresis practical improvement and critical evaluation. J Clin Chem Clin Biochem (1982) 0.75